Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Patient Expression of Emotions and Neurologist Responses in First Multiple Sclerosis Consultations

  • Lidia Del Piccolo,

    Affiliation Department of Medicine and Public Health, University of Verona, Verona, Italy

  • Erika Pietrolongo,

    Affiliation Department of Neuroscience, Imaging and Clinical Sciences, G. d’Annunzio University of Chieti-Pescara, Chieti, Italy

  • Davide Radice,

    Affiliation Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy

  • Carla Tortorella,

    Affiliation Departments of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Bari, Italy

  • Paolo Confalonieri,

    Affiliation Unit of Neuroimmunology, Foundation IRCCS Neurological Institute C. Besta, Milan, Italy

  • Maura Pugliatti,

    Affiliation Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy

  • Alessandra Lugaresi,

    Affiliation Department of Neuroscience, Imaging and Clinical Sciences, G. d’Annunzio University of Chieti-Pescara, Chieti, Italy

  • Andrea Giordano,

    Affiliation Unit of Neuroepidemiology, Foundation IRCCS Neurological Institute C. Besta, Milan, Italy

  • Christoph Heesen,

    Affiliation Institute for Neuroimmunology and Clinical MS Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

  • Alessandra Solari ,

    solari@istituto-besta.it

    Affiliation Unit of Neuroepidemiology, Foundation IRCCS Neurological Institute C. Besta, Milan, Italy

  • AutoMS Project

    Membership of the AutoMS Project is provided in the Acknowledgments.

Abstract

Background

Anxiety and depression are common in people with multiple sclerosis (MS), but data on emotional communication during MS consultations are lacking. We assessed patient expressions of emotion and neurologist responses during first-ever MS consultations using the Verona Coding Definitions of Emotional Sequences (VR-CoDES).

Methods

We applied VR-CoDES to recordings/transcripts of 88 outpatient consultations (10 neurologists, four MS Italian centers). Before consultation, patients completed the Hospital Anxiety and Depression Scale (HADS). Multilevel sequential analysis was performed on the number of cues/concerns expressed by patients, and the proportion of reduce space responses by neurologists.

Results

Patients expressed 492 cues and 45 concerns (median 4 cues and 1 concern per consultation). The commonest cues were verbal hints of hidden worries (cue type b, 41%) and references to stressful life events (type d, 26%). Variables independently associated with number of cues/concerns were: anxiety (HADS-Anxiety score >8) (incidence risk ratio, IRR 1.08, 95% CI 1.06-1.09; p<0.001); patient age (IRR 0.98, 95% CI 0.98-0.99; p<0.001); neurologist age (IRR 0.94, 95% CI 0.92-0.96; p=0.03); and second opinion consultation (IRR 0.72, 95% CI 0.60-0.86; p=0.007). Neurologists reacted to patient emotions by reducing space (changing subject, taking no notice, giving medical advice) for 58% of cues and 76% of concerns. Anxiety was the only variable significantly associated with ‘reduce space’ responses (odds ratio 2.17, 95% CI 1.32-3.57; p=0.003).

Conclusions

Patient emotional expressions varied widely, but VR-CoDES cues b and d were expressed most often. Patient anxiety was directly associated with emotional expressions; older age of patients and neurologists, and second opinion consultations were inversely associated with patient emotional expression. In over 50% of instances, neurologists responded to these expressions by reducing space, more so in anxious patients. These findings suggest that neurologists need to improve their skills in dealing with patient emotions.

Introduction

Multiple sclerosis (MS) is a chronic, degenerative disease of the central nervous system that affects women 2–3 times more often than men, and is the leading cause of non-traumatic neurologic disability in young adults [1]. Variable manifestations and unpredictable prognosis characterize the condition, which impacts on sufferers’ mental health [2], quality of life [3], and coping with the disease [4]. Depending on the ascertainment method and study population, the prevalence of depression in MS is 11–50% [510]—higher than in other chronic conditions including neurological disorders [11]. Anxiety has been less extensively assessed in MS than depression; its prevalence varies from 20 to 40% [710]. Depression and anxiety symptoms are often associated in people with MS [8,10]. Notwithstanding this, neurologists are usually less concerned with the emotional aspects of the disease than its ‘physical’ manifestations [12].

The effectiveness of patient-physician communication improves when physicians recognize and respond empathically to patient concerns [13,14]. Ability to recognize and manage patients’ emotional needs is a key feature of patient-centered care and is associated with a variety of positive patient outcomes [15], including adherence to long-term treatment [1618]. Detecting and responding to negative emotions is also important for diagnostic and therapeutic purposes [15]. Nonetheless, studies on emotional communication in various settings indicate that physicians often miss patient worries and concerns, and respond to them by providing biomedical information, or nonspecific arguments [19]. To our knowledge only one study [4] on recurrent expressions of emotions in MS patients, and how they were dealt with by the healthcare professional, has been published.

In the present study we aimed to appraise patient expressions of emotion during outpatient consultations and neurologist responses to those expressions, using the Verona Coding Definitions of Emotional Sequences (VR-CoDES) instrument [20,21]. Patient and neurologist characteristics likely to affect both outcomes were also explored.

This study is part of the international AutoMS project (Autonomy preferences, risk knowledge and decision making performance in MS patients; www.automsproject.org).

Methods

Participants and procedures

Study procedures and participant characteristics are described elsewhere [22]. Briefly, we recorded consultations with a neurologist occurring at four Italian MS centers. Eligible patients were adults able to give informed consent and who were attending for first-ever consultation (patients already being followed were excluded). Before the consultation, patients completed the Hospital Anxiety and Depression Scale (HADS) [23,24]. The consultations were unobtrusively audio-taped and transcribed verbatim.

Transcripts and audio recordings were coded according to VR-CoDES [20,21]. After EP had received two day’s training with LDP (one of the VR-CoDES authors), consultations were initially coded independently by EP and LDP, with differences resolved by discussion. After 12 consultations had been coded, only minor coding discrepancies occurred and coding was completed by EP, with only exceptional involvement by LDP.

Ethics statement

All study patients and neurologists gave written consent to participate, and for the consultation to be recorded. The protocol was approved by the Ethics Committees of the following hospitals: Foundation IRCCS Neurological Institute C. Besta, Milan; G. d’Annunzio University of Chieti-Pescara, Chieti; University of Bari; University of Sassari; all in Italy.

Measures

Verona Coding Definitions of Emotional Sequences (VR-CoDES).

The VR-CoDES [21] categorizes patient expressions of emotion as ‘cues’ (verbal or nonverbal hints, which suggest an underlying unpleasant emotion) and ‘concerns’ (clear, unambiguous verbalizations of unpleasant current or recent emotions with or without indicating their importance). Cues are further divided into seven sub-categories (Table 1) [20].

thumbnail
Table 1. The seven sub-categories of cues in the Verona Coding Definitions of Emotional Sequences (VR-CoDES) [21].

https://doi.org/10.1371/journal.pone.0127734.t001

Cues/concerns can be expressed spontaneously by the patient or elicited by the health provider. Those expressed spontaneously aim to bring up topics that the health provider has so far neglected, or not adequately explored. Health provider responses to cues/concerns are classified according to whether they provide space or reduce space for further exploration of the cue/concern [21,25,26]. The VR-CoDES manuals are available at: http://www.each.eu/verona-coding-systems.

Hospital Anxiety and Depression Scale (HADS).

HADS is a self-assessed questionnaire consisting of 14 multiple choice (0–3 Likert scale) items probing symptoms of anxiety (7 items) and depression (7 items). Anxiety (HADS-A) and depression (HADS-D) scores range from 0 (no symptoms) to 21 (most severe symptoms) [23]. The instrument has robust psychometric properties, and has been validated in several languages, including Italian [24]. Furthermore, by omitting items assessing somatic symptoms, and thereby limiting false positive findings, the scale is suitable for use in persons with medical conditions [27]. HADS is widely-used in MS patients, and cutoff scores of 8 or above are considered an accurate indicator of major depression (HADS-D) or generalized anxiety disorder (HADS-A) in this population [28].

The data which forms the basis for the analysis can be found in S1 Dataset.

Statistical analysis

Patient and neurologist characteristics were summarized by counts and percentages (categorical variables) or means and standard deviations (SDs), or medians with interquartile ranges (IQRs) (continuous variables). Group comparisons employed the chi-square test, Fisher’s exact test (categorical variables) or the Wilcoxon rank-sum test (continuous variables).

We assessed variables associated with number of expressed cues/concerns using hierarchical Poisson regression, with results presented as incidence rate ratios (IRRs) with 95% confidence intervals (CIs). Independent variables comprised: patient age, gender, education (primary vs. secondary/college), HADS-A, HADS-D, and diagnosis (MS or clinically isolated syndrome [CIS] vs. other conditions); neurologist age, gender, and years of MS experience; and whether second opinion consultation. We also assessed variables associated with neurologists’ immediate verbal responses to emotions (outcome variable: ‘reduce space’ response, same independent variables as above) using hierarchical logistic regression with results presented as odds ratios (ORs) with 95% CIs. In both types of hierarchical regression analysis, neurologists’ characteristics were nested within the MS center, and consultation length was entered as exposure (offset) variable [29,30].

The analyses were done with SAS 9.3 (SAS Institute Inc., Cary, NC, USA). All statistical tests were two-tailed; differences were considered significant at an alpha level of 0.05.

Results

Participants

Of the 117 patients approached, 25 (21%) refused and four audio recordings were incomplete and could not be rated; thus 88 consultations were transcribed and analyzed. Mean patient age was 37.5 years; 58 (66%) were women, and 63 (72%) had MS or CIS. The remaining participants had suspected MS, radiologically isolated syndrome, optic neuritis or other diagnoses (Table 2). Twenty five percent of patients came for a second opinion, 67% were employed, and 19% had a high level of education. Thirty-eight percent of patients had HADS-A score above threshold, 17% had HADS-D score above threshold, and 14% had both anxiety and depression scores above threshold.

thumbnail
Table 2. Characteristics of the 88 patients participating in the study.

https://doi.org/10.1371/journal.pone.0127734.t002

Median neurologist age was 47.5 years (range 30–51), 50% were women, and median experience with MS was 7.5 years (range 3–24). More details on participating centers, consultation type, and neurologist characteristics are reported elsewhere [22].

Patient emotional expressions and immediate neurologist responses

Overall we detected 492 VR-CoDES cues and 45 concerns, with a median of 4 cues (IQR 1–5) and 1 concern (IQR 1–2) per consultation. As shown in Table 3, verbal hints to hidden concerns (b type cues) were the most common cues (41%), followed by neutral expressions referring to stressful life events (d cues) (26%). Cue types a, c, e and f constituted less than 10% of all cues. Most cues and concerns were expressed spontaneously by patients, the only exception being c cues (related to physiological correlates of emotion). Neurologists reacted to patient emotions (58% of cues, and 76% of concerns) mainly by reducing space—i.e. by providing medical advice, switching topic, or ignoring the content of the cue; this happened significantly more often after the patient expressed a concern, and also after the patient referred to stressful life events/situations (d cue) (Table 3).

thumbnail
Table 3. Distribution of cues/concerns according to whether spontaneous or neurologist elicited and according to neurologist immediate response (reduce vs. provide space).

https://doi.org/10.1371/journal.pone.0127734.t003

Characteristics associated with patient emotional expressions and neurologist responses

Patient variables significantly associated with the total number of cues/concerns in univariate analyses (Table 4) were age (negative association, IRR 0.99, 95% CI 0.98–1.00), above-threshold anxiety (IRR 1.05, 95% CI 1.03–1.06), and above-threshold depression (IRR 1.02, 95% CI 1.00–1.04). Neurologist variables associated with total number of cues/concerns expressed were age (negative association, IRR 0.95, 95% CI 0.93–0.98), being a woman (IRR 1.65, 95% CI 1.45–1.88), and years of MS experience (IRR 1.04, 95% CI 1.03–1.05). Second opinion consultations were also negatively associated with number of expressed cues/concerns (IRR 0.56, 95% CI 0.46–0.67). In the multivariate hierarchical Poisson model (Table 4), the variables that remained significant were patient age (IRR 0.98, 95% CI 0.98–0.99), above-threshold anxiety (IRR 1.08, 95% CI 1.06–1.09), neurologist age (IRR 0.94, 95% CI 0.92–0.96), and second opinion consultation (IRR 0.72, 95% CI 0.60–0.86).

thumbnail
Table 4. Characteristics associated with patient cues and concerns in univariate and multivariate hierarchical Poisson models.

https://doi.org/10.1371/journal.pone.0127734.t004

Above-threshold anxiety was the only variable significantly associated with a ‘reduce space’ response by the neurologist (OR 2.17, 95% CI 1.32–3.57; S1 Table). No multivariable model was run.

Discussion

We investigated how MS patients manifest their emotions (as cues or explicitly expressed concerns) during first-ever consultations at MS centers, and how neurologists reacted to those expressions. Variables associated with patient emotions and neurologist responses were also explored. We found that patients expressed a median of four cues and one concern during the consultation. This is consistent with the three-to-four cues/concerns expressed by cancer patients [3133]; however patients with fibromyalgia [34] or psychiatric conditions [35] expressed more cues/concerns.

The most frequent cues identified (Table 1) were b cues (41%) followed by d cues (26%), all others were 10% or below. B cues are common in all studies that use VR-CoDES [31,34,35] perhaps because using colorful or figurative language (Table 1) is the easiest and most immediate way of expressing an affective state without mentioning emotions (Cit. 1 “There was a period… perhaps for about a month when I felt pain… back pain…. and I felt tired. It was all getting too much. I thought it was because I was working too many hours and needed to rest. Needed lots of rest. But then I found out [sigh] it wasn’t rest I needed.”

Cit. 2 “It felt like my head was going to explode. My brain would be floating… like my head was full of water and my brain was there floating in it.”)

Our study is unusual in finding a high percentage of d cues. Zhou et al. [31] found that d cues were the second most common cues (at 16%) in head and neck cancer survivors, but not as common as in our study.

This could reflect the high impact of MS on everyday life (Cit. 3 Doctor: “Why have you decided to be followed at this center [instead of Milan]? Patient: “Well, I’m still thinking about that, but it’s getting too stressful to go to Milan every three months. It doesn’t fit with my studies, my personal life… And I also get very tired… every day I feel exhausted.” Cit. 4: “This year I’ve felt really distressed, but I’ve tried to keep active by going to the gym anyway. But is it OK to do sports?”).

We found that HADS-A score above threshold was strongly and independently associated with the number of cues and concerns expressed by our patients. Other studies have also found that emotionally distressed patients expressed more cues/concerns [3639].

Regrettably, 75% of our patient expressions of concern were met by reduction of space, and this was particularly the case for anxious patients. Neurologists often switched topic, devalued emotions (Cit. 5: Patient: “I’m so lacking in energy. I can’t get up, I feel so low…” Doctor: “That’s strange. Cortisone usually picks you up. You shouldn’t be feeling so low”), ignored the emotion (Cit. 6: Patient: “Yeah, cortisone makes me feel so nervous, I’m always anxious when on cortisone…” Doctor: “Perhaps I should give you a 1.5 g cortisone boost for three days, and see how you go…”) or gave generic reassurance (Cit. 7: Patient: “I often wonder why this had to happen to me. It’s horrible. Doctor: “Yes, but, it’s not the end of the world. It may seem serious, but I have many MS patients who lead normal lives…”). Similar findings were also reported by Pollak et al. [40] in the cancer setting: in particular they found that when patients expressed negative emotions, physicians responded 73% of times with a closure statement effectively discouraging further disclosure. Similarly, in the hospital setting across different medical specialties Mjaaland et al. [41] found that most physician responses to patient cues/concerns did not include follow up or exploration. As in our study, concerns more often than cues were not given space. The authors noted [41] that while concentrating on medical aspects, hospital doctors might not realize that emotional exploration was sometimes necessary to understand the disease in a patient and tailor management to that patient’s needs.

It is noteworthy that consultations with younger patients and younger neurologists were associated with greater expression of emotions, as also reported by Butow et al. [42] in the cancer setting, and Del Piccolo et al. [35] in the psychiatric setting.

Finally, second-opinion consultations were associated with fewer expressions of emotion. This may be because the patient is more concerned with ‘technical’ issues like other possible diagnoses and treatment, so less emotional content might be expected.

Regarding the origin of emotional expression (spontaneous or neurologist-elicited), 75% of cues were spontaneous, indicating that emotional topics were rarely raised by neurologists, further indicating that emotional aspects were not for them a pressing concern. As noted above, this may be because they were concentrating on medical aspects in a consultation of limited duration. Giving information and advice (which in VR-CoDES is coded as reduction of space) is at the heart of the medical consultation; nevertheless helping patients to verbalize their feelings facilitates emotion regulation [43], predicts competent coping [44], generates greater patient satisfaction with interpersonal care [14], and increases collaboration [36].

Limitations of the present study are that a restricted number of consultations (total 88) was recorded and only 10 neurologists were involved. Furthermore the consultations were audio recorded, so some non-verbal expressions will have been missed. We did not assess whether neurologist skill in dealing with emotion affected patient satisfaction with the consultation. After the consultation, patients completed the Patient Involvement in Care Scale (PICS) [45], as a measure of patient-assessed involvement in decision-making (and thus their satisfaction with this aspect) [22]. However, our findings and those of a study in the psychiatry setting indicate that PICS is not reliable [22,46]. We therefore decided not to include PICS results in the present study. In our opinion an adequate patient-reported measure of patient satisfaction with consultations is not yet available [14].

A strength of the study is that all consultations were first contact between the patient and the neurologist (thus follow-up consultations for treatment review or other reason were excluded). To our knowledge, no studies on emotional communication during neurological consultations have been published previously.

To conclude, our findings complement those of our previous study on shared decision-making in the same consultations [22] which suggested the need to empower Italian MS neurologists with better communication and shared decision-making skills. In particular our findings indicate that physicians too often fail to respond sensitively to the emotional cues expressed by their patients, while other data suggest that sensitive responses are essential for effective shared decision making [47]. An integrated approach that retains all the elements of evidence-based medicine but adds on shared decision-making is essential for quality health care, and should be taught at all levels of medical training [48].

Supporting Information

S1 Dataset. Raw data from patients’ case record form, Hospital Anxiety and Depression Scale (HADS), and Verona Coding Definitions of Emotional Sequences (VR-CoDES).

https://doi.org/10.1371/journal.pone.0127734.s001

(XLS)

S1 Table. Characteristics associated with neurologist ‘reduce space’ response in univariate logistic regression.

https://doi.org/10.1371/journal.pone.0127734.s002

(DOCX)

Acknowledgments

We are indebted to the patients and neurologists who participated in the study. We thank Giusi Ferrari for technical assistance and data management, and Don Ward for help with the English.

AutoMS project Investigators

Steering Committee: C. Heesen8, A. Solari7 (co-chief investigators), J. Drulovic (Institute of Neurology, School of Medicine, University of Belgrade, Belgrade, Serbia), A. Giordano7, J. Kasper, S. Köpke (Institute for Social Medicine, University of Lübeck, Lübeck, Germany), A. van Nunen (National MS-Centrum, Melsbroek, Belgium).

External Advisors: L. Degner (Psychosocial Oncology and Cancer Nursing Research, University of Manitoba, Winnipeg, Canada), W. Gaissmaier (Max Planck Institute for Human Development, Berlin, Germany), C. Goss (Department of Medicine and Public Health, University of Verona, Verona, Italy).

Centers: Italy—Foundation IRCCS Neurological Institute C. Besta, Milan: A. Solari, A. Giordano, G. Ferrari, P. Confalonieri, C. Antozzi; Dept. of Neuroscience, Imaging and Clinical Sciences, G. d'Annunzio University, Chieti-Pescara, Chieti: A. Lugaresi, E. Pietrolongo, D. Farina; Dept. of Clinical and Experimental Medicine, University of Sassari, Sassari: M. Pugliatti, V. Piscedda; Departments of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Bari: M. Trojano, C. Tortorella, D. Paolicelli. Germany—Institute for Neuroimmunology and Clinical MS Research (inims), University Medical Center Hamburg-Eppendorf, Hamburg: C. Heesen, J. Kasper, I. Backhus, J Poettgen; Institute for Social Medicine, University of Lübeck, Lübeck: S. Köpke. Belgium—National MS-Centrum, Melsbroek: A. van Nunen, M. Pirard, A. Symons. Estonia—Department of Neurology, West-Tallinn Central Hospital, Tallinn: L. Vahter, K. Kannel. France—Department of Neurology. Purpan University Hospital, Toulouse: M. Clanet, F. Viala. Serbia—Institute of Neurology, School of Medicine, University of Belgrade, Belgrade: J. Drulovic, T. Pekmezovic.

Author Contributions

Conceived and designed the experiments: LDP CH AS. Performed the experiments: EP CT PC MP AL. Analyzed the data: LDP EP AG DR AS. Wrote the paper: LDP EP DR CT PC MP AL AG CH AS.

References

  1. 1. Browne P, Chandraratna D, Angood C, Tremlett H, Baker C, Taylore BV, et al. Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity. Neurology. 2014;83: 1022–1024. pmid:25200713
  2. 2. Simpson RJ, McLean G, Guthrie B, Mair F, Mercer SW. Physical and mental health comorbidity is common in people with multiple sclerosis: nationally representative cross-sectional population database analysis. BMC Neurol. 2014;14: 128. pmid:24925477
  3. 3. Mitchell AJ, Benito-Leon J, Gonzalez JM, Rivera-Navarro J. Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing. Lancet Neurol. 2005;4: 556–566. pmid:16109362
  4. 4. White CP, White M, Russell CS. Multiple sclerosis patients talking with healthcare providers about emotions. J Neurosci Nurs. 2007;39: 89–101. pmid:17477223
  5. 5. Feinstein A, Magalhaes S, Richard JF, Audet B, Moore C. The link between multiple sclerosis and depression. Nat Rev Neurol. 2014;10: 507–517. pmid:25112509
  6. 6. Giordano A, Ferrari G, Radice D, Randi G, Bisanti L, Solari A, on behalf of the POSMOS study. Self-assessed health status changes in a community cohort of people with multiple sclerosis: 11 years of follow-up. Eur J Neurol. 2013;20: 681–688. pmid:23217086
  7. 7. Giordano A, Granella F, Lugaresi A, Martinelli V, Trojano M, Confalonieri P, et al. on behalf of the SIMS-Trial group. Anxiety and depression in multiple sclerosis patients around diagnosis. J Neurol Sci. 2011;307: 86–91. pmid:21621796
  8. 8. Brown RF, Valpiani EM, Tennant CC, Dunn SM, Sharrock M, Hodgkinson S, et al. Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis. Psychol Psychother. 2009;82: 41–56. pmid:18727845
  9. 9. Dahl OP, Stordal E, Lydersen S, Midgard R. Anxiety and depression in multiple sclerosis. A comparative population-based study in Nord-Trøndelag County, Norway. Mult Scler. 2009;15: 1495–1501. pmid:19965515
  10. 10. Jones KH, Ford DV, Jones PA, John A, Middleton RM, Lockhart-Jones H, et al. A Large-Scale Study of Anxiety and Depression in People with Multiple Sclerosis: A Survey via the Web Portal of the UK MS Register. PLoS One. 2012;7: e41910. pmid:22860028
  11. 11. McGuigan C, Hutchinson M. Unrecognised symptoms of depression in a community-based population with multiple sclerosis. J Neurol. 2005;253: 219–223. pmid:16177840
  12. 12. Rothwell PM, McDowell Z, Wong CK, Dorman PJ. Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis. BMJ. 1997;314: 1580–1583. pmid:9169401
  13. 13. Adams K, Cimino JEW, Arnold RM, Anderson WG. Why should I talk about emotion? Communication patterns associated with physician discussion of patient expressions of negative emotion in hospital admission encounters. Patient Educ Couns. 2012;89: 44–50. pmid:22575434
  14. 14. Epstein RM, Hadee T, Carroll J, Meldrum SC, Lardner J, Shields CG. "Could this be something serious?" Reassurance, uncertainty, and empathy in response to patients' expressions of worry. J Gen Intern Med. 2007;22: 1731–1739. pmid:17972141
  15. 15. Street RL, Makoul G, Arora NK, Epstein RM. How does communication heal? Pathways linking clinician—patient communication to health outcomes. Patient Educ Couns. 2009;74: 295–301. pmid:19150199
  16. 16. Joosten EAG, DeFuentes-Merilla L, de Weert GH, Sensky T, van der Staak CPF, de Jong CA. Systematic review of the effects of shared decision making on patient satisfaction, treatment adherence and health status. Psychother Psychosom. 2008;77: 219–226. pmid:18418028
  17. 17. King JS, Moulton BW. Rethinking informed consent: The case for shared medical decision-making. Am J Law Med. 2006;32: 429–501. pmid:17240730
  18. 18. Devonshire V, Lapierre Y, Macdonell R, Ramo-Tellod C, Patti F, Fontoura P, et al. The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis. Eur J Neurol. 2011;18: 69–77. pmid:20561039
  19. 19. Finset A. ‘‘I am worried, Doctor!” Emotions in the doctor—patient relationship. Patient Educ Couns. 2012;88: 359–363. pmid:22819270
  20. 20. Zimmermann C, Del Piccolo L, Bensing J, Bergvik S, De Haes H, Eide H, et al. Coding patient emotional cues and concerns in medical consultations: The Verona coding definitions of emotional sequences (VR-CoDES). Patient Educ Couns. 2011;82: 141–148. pmid:20430562
  21. 21. Del Piccolo L, de Haes H, Heaven C, Jansen J, Verheul W, Bensing J, et al. Development of the Verona Coding Definitions of Emotional Sequences to code health providers’ responses (VR-CoDES-P) to patient cues and concerns. Patient Educ Couns. 2011;82: 149–155. pmid:20346609
  22. 22. Pietrolongo E, Giordano A, Kleinefeld M, Confalonieri P, Lugaresi A, Tortorella C, et al. on behalf of the AutoMS project. Decision-making in multiple sclerosis consultations in Italy: third observer and patient assessments. PLoS One. 2013;8: e60721. pmid:23565270
  23. 23. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67: 361–370. pmid:6880820
  24. 24. Costantini M, Musso M, Viterbori P, Bonci F, Del Mastro L, Garrone O, et al. Detecting psychological distress in cancer patients: validity of the Italian version of the Hospital Anxiety and Depression Scale. Support Care Cancer. 1999;7: 121–127. pmid:10335929
  25. 25. Eide H, Quera V, Graugaard P, Finset A. Physician—patient dialogue surrounding patients’ expression of concern: applying sequence analysis to RIAS. Soc Sci Med. 2004;59: 145–155. pmid:15087150
  26. 26. Del Piccolo L, Mazzi MA, Dunn G, Sandri M, Zimmermann C. Sequence analysis in multilevel models. A study on different sources of patient cues in medical consultations. Soc Sci Med. 2007;65: 2357–2370. pmid:17868965
  27. 27. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale—a review of validation data and clinical results. J Psychosom Res. 1997;42: 17–41. pmid:9055211
  28. 28. Honarmand K, Feinstein A. Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients. Mult Scler. 2009;15: 1518–1524. pmid:19965520
  29. 29. Vatne T, Finset A, Ruland C. Application of the Verona Coding Definitions of Emotional Sequences (VR-CoDES) on a pediatric data set. Patient Educ Couns. 2010;80: 399–404. pmid:20663629
  30. 30. Eide H, Eide T, Rustøen T, Finset A. Patient validation of cues and concerns identified according to Verona coding definitions of emotional sequences (VR-CoDES): A video- and interview-based approach. Patient Educ Couns. 2011;82: 156–162. pmid:20570460
  31. 31. Zhou Y, Humphris G, Ghazali N, Friderichs S, Grosset D, Rogers SN. How head and neck consultants manage patients’ emotional distress during cancer follow-up consultations: a multilevel study. Eur Arch Otorhinolaryngol. 2014 Jul 31.
  32. 32. Finset A, Heyn L, Ruland C. Patterns in clinicians’ responses to patient emotion in cancer care. Patient Educ Couns. 2013;93: 80–85. pmid:23850184
  33. 33. Oguchi M, Jansen J, Butow P, Colagiuri B, Divine R, Dhillon H. Measuring the impact of nurse cue-response behavior on cancer patients’ emotional cues. Patient Educ Couns. 2011;82: 163–168. pmid:20430567
  34. 34. Eide H, Sibbern T, Egeland T, Finset A, Johannessen T, Miaskowski C, et al. Fibromyalgia patients' communication of cues and concerns: Interaction analysis of pain clinic consultations. Clin J Pain. 2011;27: 602–610. pmid:21430524
  35. 35. Del Piccolo L, Mazzi MA, Goss C, Rimondini M, Zimmermann C. How emotions emerge and are dealt with in first diagnostic consultations in psychiatry. Patient Educ Couns. 2012;88: 29–35. pmid:22326453
  36. 36. Davenport S, Goldberg D, Millar T. How psychiatric disorders are missed during medical consultations. Lancet. 1987; 22: 439–441.
  37. 37. Del Piccolo L, Saltini A, Zimmermann C, Dunn G. Differences in verbal behaviours of patients with and without emotional distress during primary care consultations. Psychol Med. 2000;30: 629–643. pmid:10883718
  38. 38. Del Piccolo L, Mead N, Gask L, Mazzi MA, Goss C, Rimondini M, et al. The English version of the Verona Medical Interview Classification System (VR-MICS): an assessment of its reliability and a comparative cross-cultural test of its validity. Patient Educ Couns. 2005;58: 252–264. pmid:16122640
  39. 39. Hall JA, Roter DL, Milburn MA, Daltroy LH. Patients' health as a predictor of physician and patient behavior in medical visits. A synthesis of four studies. Med Care.1996;34: 1205–1218. pmid:8962587
  40. 40. Pollak KI, Arnold RM, Jeffreys AS, Alexander SC, Olsen MK, Abernethy AP, et al. Oncologist communication about emotion during visits with patients with advanced cancer. J Clin Oncol. 2007; 25: 5748–5752. pmid:18089870
  41. 41. Mjaaland TA, Finset A, Jensen BF, Gulbrandsen P. Physicians' responses to patients' expressions of negative emotions in hospital consultations: A video-based observational study Patient Educ Couns. 2011;84: 332–337.
  42. 42. Butow PN, Brown RF, Gogar S, Tattersall MH, Dunn SM. Oncologists reaction to cancer patients’ verbal cues. Psycho-oncology. 2002;11: 47–58. pmid:11835592
  43. 43. Zachariae R, Pedersen CG, Jensen AB, Ehrnrooth E, Rossen PB, von der Maase H. Association of perceived physician communication style with patient satisfaction, distress, cancer-related self-efficacy, and perceived control over the disease. Br J Cancer. 2003;88: 658–665. pmid:12618870
  44. 44. Little P, Everitt H, Williamson I, Warner G, Moore M, Gould C, et al. Observational study of effect of patient centredness and positive approach on outcomes of general practice consultations. BMJ. 2001;323: 908–911. pmid:11668137
  45. 45. Lerman CE, Brody DS, Caputo GC, Smith DG, Lazaro CG, Wolfson HG. Patients’ Perceived Involvement in Care Scale: relationship to attitudes about illness and medical care. J Gen Intern Med. 1990;5: 29–33. pmid:2299426
  46. 46. Goossensen A, Zijlstra P, Koopmanschap M. Measuring shared decision making processes in psychiatry: skills versus patient satisfaction. Patient Educ Couns. 2007;67: 50–56. pmid:17350214
  47. 47. Silverman J, Kurtz S, Draper J. Skills for communicating with patients. 3rd edn. London: Radcliff Publishing; 2013. 68 p.
  48. 48. Hoffmann TC, Montori VM, Del Mar C. The connection between evidence-based medicine and shared decision making. JAMA. 2014; 312: 1295–1296. pmid:25268434